ARGENX
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97727259
- Registration number
- 7491300
- Mark type
- Design + words
- Filed
- 21 Dec 2022
- Published for opposition
- 18 Jun 2024
- Registered
- 03 Sept 2024
- Attorney of record
- Edward T. White
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
- Class 035 — Advertising and business services: Wholesale and retail store services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing services and patient information services namely, providing consumer product information in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information, namely, providing consumer product information relating to pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs
- Class 042 — Scientific and technological services: Research and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research, design, analysis, and testing in the field of immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development
- Class 044 — Medical, beauty and agricultural services: Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and medical information services relating to biopharmaceutical products
Owner
- argenx B.V., Zwijnaarde, BE
- argenx B.V., Zwijnaarde, BE
- argenx B.V., Zwijnaarde, BE
Prosecution history
- 03 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 03 Sept 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 03 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2024 — POST PUBLICATION AMENDMENT - ENTERED
- 10 Jul 2024 — ASSIGNED TO PETITION STAFF
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 10 Jun 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED